IMP761 — Conference presentation
Nov 10
Details of the presentation are as follows: Title IMP761, a Novel Immunosuppressive Lymphocyte Activation Gene-3 (LAG-3) Agonist Antibody in the Clinic Trial IMP761-P001 (NCT06637865) Session category Late-Breaking Abstract Poster Session (LB01–LB18) First Author Christian Mueller, Chief Development Officer, Immutep Presentation # LB09 Date and time Tuesday, November 10, 2026, 10:30 AM – 12:30 PM ETSource filing